secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2025-11-21T23:59:59+00:00
Accession:  0001999371-25-018392
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix Pharmaceuticals increases ATM equity offering capacity from $150M to $400M
--------------------------------------------------------------------------------

- Sales Agreement with A.G.P./Alliance Global Partners amended to raise maximum aggregate offering price to $400M from $150M.
- Amendment dated November 21, 2025; shares to be sold through at-the-market (ATM) issuance.
- Company filed legal opinion from Brownstein Hyatt Farber Schreck on share legality.
- Fundraising capacity more than doubled; no stated use of proceeds in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000199937125018392/0001999371-25-018392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000199937125018392/tnxp-8k_112125.htm
  HTML page:      https://secwatch.observer/filing/0001999371-25-018392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer